EditorialDeclining Incidence of Systolic Left Ventricular Dysfunction in Human Immunodeficiency Virus–Infected Individuals Treated With Highly Active Antiretroviral Therapy
Section snippets
Acknowledgment
The authors thank the Pediatric HIV/AIDS Cohort Study network for their logistical support of this work.
References (16)
- et al.
Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study
Am Heart J
(2005) - et al.
Heart muscle disease related to HIV infection: prognostic implications
BMJ
(1994) - et al.
Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort
Eur Heart J
(2012) - et al.
Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America
J Int AIDS Soc
(2013) - et al.
Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study
Circulation
(1998) - et al.
The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1
AIDS
(2012) - et al.
HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults
Expert Rev Anti Infect Ther
(2012) - et al.
Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients
Am J Cardiovasc Drugs
(2011)
There are more references available in the full text version of this article.
Cited by (0)
See page 1195 for disclosure information.
Copyright © 2016 Elsevier Inc. All rights reserved.